Pfizer Venture Investments vs Sofinnova Ventures
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Pfizer Venture Investments | Sofinnova Ventures | |
|---|---|---|
| Type | Corporate VC | Venture capital |
| HQ | — | Menlo Park |
| Founded | 2004 | 1976 |
| Check size | $5M – $20M | $100K – $15M |
| Stages | Seed, Series A, Series B, Series C, Growth, Late Stage | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | AI & Machine Learning, Biotech, Healthtech, Medical Devices | Biotech, Digital Health, Healthtech, Medical Devices |
| AUM | — | $5.4B |
| Tracked investments | 186 | 177 |
| Exits (acquired/public) | 4 | 3 |
| Led rounds on record | — | 1 |
| Dated deals, last 24 mo | — | 6 |
Shared portfolio · 5
MerusSynlogicOcera Theraputicsvisit ww.nextcure.comvisit www.capstantx.com
Frequently asked questions
- Do Pfizer Venture Investments and Sofinnova Ventures invest together?
- Yes — Pfizer Venture Investments and Sofinnova Ventures appear together in 5 tracked portfolio companies, including Merus, Synlogic, Ocera Theraputics, visit ww.nextcure.com, visit www.capstantx.com.
- How do Pfizer Venture Investments and Sofinnova Ventures compare on check size?
- Pfizer Venture Investments typically writes checks of $5M – $20M, while Sofinnova Ventures writes $100K – $15M.